Levodopa acts centrally to induce an antinociceptive action against colonic distension through activation of D2 dopamine receptors and the orexinergic system in the brain in conscious rats

Journal of Pharmacological Sciences
T OkumuraMasumi Ohhira

Abstract

Levodopa possesses antinociceptive actions against several somatic pain conditions. However, we do not know at this moment whether levodopa is also effective to visceral pain. The present study was therefore performed to clarify whether levodopa is effective to visceral pain and its mechanisms. Visceral sensation was evaluated by colonic distension-induced abdominal withdrawal reflex (AWR) in conscious rats. Subcutaneously (80 mg/rat) or intracisternally (2.5 μg/rat) administered levodopa significantly increased the threshold of colonic distension-induced AWR in conscious rats. The dose difference to induce the antinociceptive action suggests levodopa acts centrally to exert its antinociceptive action against colonic distension. While neither sulpiride, a D2 dopamine receptor antagonist, nor SCH23390, a D1 dopamine receptor antagonist by itself changed the threshold of colonic distension-induced AWR, the intracisternally injected levodopa-induced antinociceptive action was significantly blocked by pretreatment with subcutaneously administered sulpiride but not SCH23390. Treatment with intracisternal SB334867, an orexin 1 receptor antagonist, significantly blocked the subcutaneously administered levodopa-induced antinociceptive ...Continue Reading

References

Apr 13, 1972·The New England Journal of Medicine·R P Dickey, J P Minton
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·L de LeceaJ G Sutcliffe
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y DateM Nakazato
Jan 28, 1999·Biochemical and Biophysical Research Communications·N TakahashiY Kohgo
Mar 17, 2001·British Journal of Pharmacology·D SmartJ C Jerman
Jul 28, 2004·Pain·Takao ShimizuMasahiro Nomoto
May 9, 2006·Gastroenterology·George F LongstrethRobin C Spiller
Sep 4, 2010·Brain Research Bulletin·Nuria CobachoCarlos L Paíno
May 18, 2011·Neuroscience Letters·Tsukasa NozuToshikatsu Okumura
Mar 27, 2012·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·L WangY Taché
Aug 1, 2013·World Journal of Gastroenterology : WJG·Qing-Lin TangMing-Qing Zhang
Oct 2, 2014·ACS Chemical Neuroscience·A Connor WhitfieldR Nathan Daniels
Dec 21, 2014·Brain Research·Toshikatsu OkumuraMasumi Ohhira

❮ Previous
Next ❯

Citations

May 4, 2018·Acupuncture in Medicine : Journal of the British Medical Acupuncture Society·Xianwei ZhuJing Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.